Biotech Investment Analyst - Drug Asset & Company Assessment

This role is for one of our clients

Compensation: $120 - $200 per hour

We are partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.